ligandreceptor
interact
customarili
describ
equat
appli
solut
yet
receptor
present
cell
membran
suffici
lipophil
ligand
could
reach
receptor
twodimension
approach
within
membran
summar
review
may
affect
ligandreceptor
interact
mani
way
biophysician
calcul
compar
threedimension
approach
liquid
phase
approach
could
alter
time
ligand
need
find
receptor
biochemist
found
ligand
incorpor
lipid
bilay
modifi
conform
along
depth
ligand
resid
bilay
affect
probabl
success
receptor
interact
novel
mechan
also
introduc
includ
exosit
bind
ligand
transloc
receptor
transmembran
domain
pharmacologist
focus
attent
ligand
concentr
membran
adsorpt
releas
rate
effect
thereof
ligand
potenc
resid
time
receptor
g
vauquelin
physic
biochemistri
pharmacolog
biolog
chemistri
contribut
better
knowledg
membran
may
affect
ligandreceptor
well
substrateenzym
interact
molecular
level
ambit
review
integr
outcom
studi
singl
comprehens
monograph
stimul
interdisciplinari
crosstalk
far
obsolet
topic
ligandreceptor
interact
customarili
describ
equat
appli
solut
ie
molecul
homogen
distribut
solvent
free
move
therein
yet
neurotransmitt
receptor
channelassoci
receptor
hormon
receptor
integr
compon
cell
plasma
membran
creat
inhomogen
receptor
distribut
may
profoundli
affect
molecular
kinet
characterist
interact
ligand
provid
suffici
lipophil
past
forti
year
expert
belong
disciplin
like
bio
diffus
play
emin
role
biolog
microscop
viewpoint
reflect
brownian
motion
ie
random
walk
molecul
solut
result
continu
collis
molecul
solvent
water
statist
treatment
behavior
larg
set
random
walk
formul
classic
equat
macroscop
see
front
matter
elsevi
ireland
ltd
right
reserv
fig
repres
exampl
path
taken
ligand
reach
receptor
target
surfac
membran
black
dot
via
exclus
approach
left
panel
via
mix
approach
right
panel
wang
et
al
sion
first
introduc
adolf
fick
vivo
well
appropri
surrog
vitro
experiment
system
solubl
molecul
solut
occasion
collid
obstruct
like
cell
membran
extracellular
matrix
earli
mathemat
treatment
cell
membran
consid
constitut
perfectli
reflect
barrier
solut
bounceoff
immedi
collis
calcul
reveal
first
collis
like
solut
collid
surfac
drift
away
bulk
solut
berg
purcel
receptor
natur
messeng
like
hormon
neurotransmitt
embed
cell
plasma
membran
interact
messeng
relat
ligand
customarili
describ
equat
appli
interact
two
solut
ie
molecul
homogen
distribut
free
move
solut
yet
compar
enorm
size
cell
even
isol
membran
fragment
thereof
diffus
ligand
molecul
need
taken
account
moreov
sinc
receptor
cover
minut
fraction
total
surfac
cell
plasma
membran
direct
hit
free
ligand
receptor
probabl
rare
event
pioneer
calcul
influenc
surfac
heterogen
reaction
berg
purcel
conclud
like
ligand
make
encount
nonspecif
area
membran
consid
repres
reflect
surfac
interact
embed
receptor
target
drift
away
fig
left
panel
initi
tendenc
ligand
remain
close
proxim
membran
surfac
higher
probabl
hit
receptor
within
given
timespan
compar
situat
ligand
isol
receptor
molecul
homogen
distribut
freeli
diffus
solut
berg
purcel
word
mere
base
physic
characterist
membran
alreadi
abl
boost
rate
ligandreceptor
encount
note
well
mani
ensu
calcul
receptor
repres
trap
perfect
sink
ie
somewhat
similar
hole
snooker
tabl
hit
receptor
result
immedi
irrevers
disappear
ligand
molecul
question
practic
cell
membran
abl
undergo
electrostat
hydrophob
interact
solut
mani
instanc
small
ligand
molecul
even
peptid
becom
absorb
membranesolut
interfac
case
highli
hydrophob
ligand
even
becom
complet
embed
within
membran
sargent
et
al
herbett
et
al
henc
behavior
membran
quit
distinct
perfectli
reflect
barrier
base
thereon
adam
first
introduc
idea
rate
membraneassoci
trap
react
dissolv
ligand
enhanc
ligand
first
absorb
surfac
membran
later
diffus
trap
reduct
dimension
theori
impli
rather
approach
receptor
pure
threedimension
diffus
ligand
first
direct
diffus
nonspecif
region
membran
surfac
follow
adsorpt
twodimension
diffus
surfac
even
within
membran
receptor
fig
right
panel
consider
obvious
impli
ligand
question
abl
perform
final
approach
receptor
rout
ie
without
need
temporarili
leav
lipid
bilay
reach
receptor
within
aqueou
phase
conclus
evid
surfac
diffus
receptor
target
provid
patch
clamp
experi
dihydropyridin
dhp
deriv
cultur
rat
myocardi
cell
neonat
rat
adult
guinea
pig
ventricular
cell
inde
shown
ad
medium
outsid
patch
ligand
anyhow
abl
affect
singl
calcium
channel
within
patch
kokubun
reuter
brown
et
al
sinc
receptor
make
part
calcium
channel
physic
isol
bulk
solvent
ie
presenc
within
patch
dhp
reach
receptor
lipid
bilay
instead
aqueou
approach
moreov
agreement
thermodynam
highli
unfavor
flipflop
amphiphil
molecul
leaflet
plasma
membran
ioniz
dhp
interact
calcium
channel
appli
correct
side
membran
bangalor
et
al
major
outcom
adam
calcul
inde
averag
mix
approach
allow
ligand
reach
receptor
shorter
rout
case
exclus
approach
base
consider
increas
effici
multimolecular
reaction
process
low
concentr
eigen
went
even
one
step
suggest
reduct
dimension
natur
trick
overcom
barrier
diffus
control
could
explain
preval
membranebound
enzym
live
system
subsequ
calcul
done
aim
find
condit
reduct
dimension
favor
impact
collis
rate
ligandsubstr
membraneassoci
receptorenzym
respect
import
paramet
taken
consider
ligand
concentr
solut
receptor
concentr
ie
amount
receptor
per
unit
membran
surfac
area
distribut
pattern
receptor
homogen
dispers
vs
accumul
discret
area
lipid
raft
diffus
rate
constant
ligand
denot
respect
ligand
affin
nonspecificnontarget
site
membran
occasion
also
correspond
nonspecif
adsorpt
releas
rate
constant
ligand
gener
captur
rate
ie
steadyst
flux
adsorb
ligand
receptorstrap
via
combin
pathway
found
increas
upon
increas
ligand
affin
nonspecif
site
membran
given
equilibrium
dissoci
constant
k
eq
mole
l
aqueou
solut
surfac
diffus
coeffici
respect
noteworthi
ligand
need
possess
overli
high
affin
membran
favor
combin
approach
berg
purcel
wang
et
al
exampl
rel
low
affin
acth
nonspecif
site
membran
k
eq
calcul
alreadi
strong
enough
increas
speedlikelihood
ligand
find
receptor
upon
switch
rout
random
diffus
solut
search
within
plane
membran
sargent
et
al
moreov
twostep
search
also
found
yield
rate
advantag
case
low
bulk
ligand
receptor
target
concentr
adam
berg
purcel
rhode
et
al
mccloskey
poo
wang
et
al
exampl
low
dhp
receptor
densiti
cardiac
sarcolemm
membran
ie
sitem
rhode
et
al
calcul
mean
time
ligandreceptor
collis
via
combin
time
smaller
mean
time
collis
via
pathway
yet
differ
model
restrict
assumpt
calcul
alway
yield
outcom
wang
et
al
led
proclaim
strict
guarante
ligand
find
membraneassoci
receptor
quickli
aid
surfac
diffus
even
nearli
high
ligand
possess
moder
affin
membran
mccloskey
poo
respect
diffus
rate
small
molecul
may
vari
wide
less
rate
fluoresc
label
antagonist
membran
high
rate
molecul
diffus
central
disorgan
part
artifici
membran
mccloskey
poo
addit
caveat
model
paid
attent
diffusionlimit
ligandreceptor
interact
facilit
calcul
receptor
regard
act
irrevers
absorb
perfect
sink
distinct
featur
perfect
sink
even
steadi
state
induc
local
deplet
solubl
ligand
molecul
around
axelrod
wang
yet
assumpt
fit
experiment
find
indic
receptor
usual
bind
ligand
revers
fashion
releas
unalt
back
solut
impli
local
deplet
zone
rare
exist
steadi
state
condit
henc
perfect
sink
model
accur
describ
realworld
situat
wang
et
al
even
import
conceptu
turn
point
provid
rhode
et
al
author
notic
experiment
dhpreceptor
associ
rate
far
lower
one
calcul
basi
diffus
therefor
conclud
bind
ligand
reaction
limit
reflect
small
probabl
diffus
ligandreceptor
encount
result
success
bind
rather
mere
diffus
limit
subsequ
observ
axelrod
wang
explor
outcom
model
collis
ligand
rare
lead
bind
receptor
creat
signific
local
deplet
zone
ligand
quit
similar
outcom
previou
calcul
base
perfect
sink
model
shown
reduct
dimension
could
exhibit
signific
rate
enhanc
drug
concentr
solut
k
eq
low
larg
receptor
target
far
apart
rel
contribut
ligand
diffus
probabl
success
bind
format
dissoci
bimolecular
ligandreceptor
complex
address
comprehens
model
first
introduc
delisi
cowork
delisi
delisi
wiegel
model
stipul
bind
ligand
l
receptor
r
proce
accord
twostep
process
diffus
ligand
first
bring
within
short
distanc
one
anoth
socal
reaction
distanc
encount
complex
l
r
form
bind
process
format
take
place
specif
reaction
forward
rate
constant
k
fig
left
panel
model
neatli
separ
ligandreceptor
bind
two
part
one
depend
viscos
medium
manifest
diffus
rate
constant
k
k
depend
reaction
mechan
manifest
k
k
also
repres
singlestep
process
effect
forward
rate
constant
k
f
k
k
k
k
effect
revers
rate
constant
k
r
k
k
k
k
fig
right
panel
inher
model
impli
mix
approach
could
provid
rate
advantag
approach
partit
ligand
membran
allow
adopt
adequ
posit
orient
andor
conform
rhode
et
al
chester
et
al
issu
address
detail
obtain
equilibr
ligand
aqueou
solvent
buffer
medium
membran
fraction
equilibrium
partit
coeffici
k
p
calcul
divid
ligand
concentr
membran
mole
l
membran
ligand
concentr
solvent
mole
l
solut
k
p
dimensionless
confus
ligand
equilibrium
dissoci
constant
k
eq
bind
nonspecif
site
membran
respect
experiment
model
use
estim
k
p
valu
wide
accept
partit
ligand
biolog
membran
artifici
phospholipid
bilay
system
adequ
previous
wide
use
isotrop
twophas
bulk
solvent
system
octanolbuff
combin
inde
latter
experi
provid
inform
hydrophob
ligand
without
take
account
abil
ligand
interact
polar
head
group
membran
lipid
mason
et
al
line
theoret
consider
partit
coeffici
dhp
dopamin
receptor
antagonist
membran
membran
lipid
differ
report
octanolwat
combin
fig
oliveira
et
al
mason
et
al
howev
use
synthet
membran
k
p
determin
one
also
need
awar
import
contribut
physic
state
eg
influenc
temperatur
thereon
phospholipid
composit
even
cholesterol
content
mason
et
al
exampl
k
p
dhp
incorpor
lipid
bilay
found
invers
relat
cholesterol
content
herbett
k
p
elev
conceiv
high
concentr
ligand
molecul
membran
play
emin
role
boost
rate
receptor
associ
ie
associ
rate
constant
multipli
local
ligand
concentr
faster
access
receptor
diffus
mason
mason
et
al
mason
et
al
et
al
word
even
diffus
essenti
nonexist
increas
local
ligand
concentr
membran
partit
could
produc
rate
advantag
compar
pure
approach
line
high
affin
bind
could
mere
consequ
elev
concentr
ligand
membran
sargent
schwyzer
inde
convent
equilibrium
dissoci
constant
ligandreceptor
interact
k
express
mole
l
aqueou
solut
could
defin
k
k
k
p
k
local
equilibrium
dissoci
constant
mason
et
al
castanho
fernand
howev
k
p
base
calcul
would
still
underestim
true
concentr
ligand
vicin
receptor
ligand
molecul
confin
discret
portion
bilay
mason
et
al
whatev
pertin
assert
point
crucial
aspect
membran
partit
name
highli
order
structur
lipid
bilay
amphiphil
lipophil
ligand
align
within
membran
bilay
prefer
orient
locat
accord
electron
stereochem
properti
henc
physic
characterist
ligand
may
contribut
discret
depth
tend
resid
within
membran
depth
defin
center
gaussian
curv
reflect
distribut
profil
drug
lipid
bilay
mason
et
al
locat
may
affect
k
p
suggest
compar
studi
herbett
et
al
fig
amiodaron
found
locat
deep
within
bilay
close
end
phospholipid
fatti
acid
tail
bilay
center
highest
k
p
valu
b
propranolol
nimodipin
dhp
closer
hydrocarbon
corewat
interfac
bilay
exhibit
smaller
k
p
valu
locat
facilit
hydrophob
interact
phospholipid
acyl
chain
electrostat
interact
amino
function
ligand
phosphat
head
group
base
observ
hydrophob
amphiphil
ligand
tend
resid
discret
depth
within
membran
propos
bind
domain
receptor
face
bilay
depth
activ
portion
ligand
rhode
et
al
chester
et
al
castanho
fernand
line
view
structureact
relationship
mutat
studi
suggest
dhp
bind
site
locat
transmembran
tm
domain
ltype
calcium
channel
approxim
extern
membran
surfac
bangalor
et
al
site
locat
alloster
respect
calciumbind
site
channel
peterson
catteral
mutat
experi
g
proteincoupl
receptor
gpcr
point
bind
pocket
small
natur
messeng
small
competit
ligand
deepli
embed
within
central
cleft
form
seven
membranespan
domain
tm
domain
wherea
bind
pocket
tradit
consid
access
hydrophil
ligand
resid
aqueou
phase
alreadi
propos
sever
occas
membraneassoci
amphiphil
lipophil
ligand
could
still
gain
access
via
later
diffus
receptor
tm
domain
receptor
fig
pathway
propos
number
ligand
fig
like
endogen
cb
cannabinoid
receptor
agonist
anandamid
synthet
adrenerg
receptor
agonist
salmeterol
type
angiotensin
ii
receptor
antagonist
losartan
dopamin
receptor
antagonist
spiperon
anderson
anderson
et
al
theodoropoul
marsh
zoumpoulaki
et
al
mavromoustako
et
al
makriyanni
et
al
tian
et
al
packeu
et
al
anadamantin
fig
store
cellular
compart
produc
upon
demand
cell
membran
phospholipid
compon
convey
special
carrier
protein
presynapt
nerv
termin
incorpor
plasma
membran
membran
anadamantin
like
adopt
extend
conform
head
group
near
lipidwat
interfac
end
fatti
acid
tail
near
bilay
center
barnettnorri
et
al
lynch
reggio
allow
anandamid
engag
cb
receptor
fast
later
diffus
within
membran
tian
et
al
respect
bxxb
motif
form
beta
branch
amino
acid
lipid
face
cb
receptor
inact
state
propos
serv
initi
interact
site
anandamid
lynch
reggio
fatti
acid
tail
agonist
inde
locat
correct
depth
bilay
interact
motif
cannabinerg
compound
gener
amphiphil
natur
well
although
like
bind
distinct
pocket
cb
receptor
also
thought
reach
pocket
later
diffus
within
membran
xie
et
al
murphi
kendal
makriyanni
et
al
tian
et
al
price
et
al
lynch
reggio
kapur
et
al
interestingli
survey
sequenc
data
lynch
reggio
indic
match
bxxb
motif
also
born
sever
gpcr
lipidderiv
ligand
like
cb
cannabinoid
recep
tor
oxoeicosanoid
receptor
sever
lysosphingolipid
prostanoid
receptor
salmeterol
fig
amphiphil
synthet
adrenerg
receptor
agonist
consist
hydrophil
saligenin
head
respons
receptor
activ
extend
lipophil
phenylalkoxyalkyl
side
chain
respons
high
partit
synthet
membran
rhode
et
al
bergend
et
al
similar
phospholipid
salmeterol
long
assum
specif
orient
membran
prone
flipflop
face
membran
rhode
et
al
johnson
et
al
agonist
consid
accomplish
approach
well
later
diffus
receptor
tm
domain
johnson
et
al
anderson
et
al
coleman
et
al
teschemach
lemoin
hydrophil
saligenin
head
necessari
receptor
activ
propos
phenylalkoxyalkyl
side
chain
interact
nonpolar
region
cell
membran
close
vicin
receptor
exosit
johnson
et
al
clark
et
al
allow
saligenin
head
freeli
reach
leav
central
core
adrenerg
receptor
hing
principl
fig
model
provid
also
eleg
explan
fast
termin
salmeterol
respons
presenc
hydrophil
antagonist
like
sotalol
fast
reappear
reassert
respons
antagonist
wash
away
even
though
washout
medium
salmeterolfre
ball
et
al
et
al
voss
oxygen
atom
alkyloxalkyl
side
chain
propos
act
point
support
pivot
saligenin
head
johnson
respect
structureact
relationship
studi
point
import
role
posit
alkyloxalkyl
side
chain
therefor
propos
effici
saligenin
head
pivotingdock
process
dictat
averag
depth
hing
membran
herbett
chester
et
al
mason
et
al
castanho
fernand
combin
approach
ligand
abl
perform
final
approach
receptor
without
need
temporarili
leav
lipid
bilay
yet
also
appli
ligand
whose
reactiv
group
need
approach
receptor
aqueou
phase
provid
anoth
portion
molecul
still
tether
membran
axelrod
elegantli
demonstr
experi
involv
fatti
acid
attach
peptid
hormon
analogu
like
thr
nle
cck
nle
humangastrin
romano
et
al
morod
et
al
morod
start
short
lipid
chain
initi
elong
decreas
affin
lipogastrin
peptid
construct
respect
receptor
lipid
chain
still
short
permit
firm
attach
construct
membran
still
suppos
escap
membran
first
reach
receptor
bind
site
via
aqueou
phase
henc
effect
initi
lipid
chain
elong
affin
construct
relat
fact
becam
difficult
escap
membran
howev
escap
longer
possibl
lipid
chain
length
beyond
explain
chain
elong
longer
produc
substanti
decreas
receptor
affin
latter
find
suggest
extracellular
loop
domain
involv
gpcr
suffici
flexibl
mobil
permit
later
penetr
peptid
head
group
waterlipid
interfac
reach
bind
site
central
cleft
receptor
fig
lutz
et
al
also
impli
segment
peptid
suffici
hydrophob
charact
like
provok
spontan
partit
peptid
membran
sargent
et
al
henc
combin
approach
could
also
appli
certain
peptid
ligand
socal
nonspecif
natur
ligandmembran
interact
like
misconcept
inde
rather
mere
control
ligand
approach
kinet
local
accumul
plasma
membran
interact
could
also
affect
receptor
bind
process
exert
translat
conform
orient
constraint
ligand
specif
structur
basi
sargent
schwyzer
rhode
et
al
schwyzer
bader
et
al
respect
noteworthi
appli
small
amphiphil
ligand
molecul
also
peptid
messeng
like
gastrin
cck
npi
bader
et
al
castanho
fernand
stone
et
al
regulatori
peptid
uniqu
structur
solut
acquir
welldefin
conform
upon
interact
membran
sargent
et
al
contrera
et
al
hydrophob
interact
certainli
play
import
role
process
peptid
gener
assum
amino
acid
fig
panel
insert
hydrophob
peptid
segment
membran
bokvist
et
al
panel
b
simplifi
scheme
membran
catalysi
model
sargent
schwyzer
partit
conform
chang
peptid
ligand
describ
singl
equilibrium
step
defin
kp
k
local
equilibrium
dissoci
constant
refer
ligand
concentr
membran
half
receptor
occupi
overal
equilibrium
dissoci
constant
ligandreceptor
interact
kd
express
mole
l
aqueou
solut
correspond
kd
k
k
p
hydrophob
residu
form
alpha
helic
penetr
perpendicularli
lipid
bilay
gremlich
et
al
sargent
schwyzer
bokvist
et
al
line
acth
substanc
p
dynorphin
found
adopt
partial
helic
structur
solvent
mimic
lipid
environ
greff
et
al
ern
et
al
sargent
et
al
yet
peptidemembran
interact
could
also
compris
import
electrostat
compon
clearli
demonstr
case
peptidesarsifp
sever
acut
respiratori
syndrom
coronaviru
sequenc
amino
acid
interact
differ
membran
depend
charg
phospholipid
bokvist
et
al
line
amino
acid
long
amphiphil
peptid
main
constitu
found
extracellular
amyloid
plaqu
brain
alzheim
diseas
patient
like
insert
plasma
membran
hydrophob
domain
prior
releas
respect
experi
reveal
short
part
peptid
insert
neutral
lipid
bilay
fig
hydrophil
part
peptid
stabil
bulk
solut
howev
insert
becom
pronounc
upon
increas
membran
surfac
potenti
emerg
electrostat
anchor
charg
peptid
residu
close
membran
surfac
bokvist
et
al
electrostat
hydrophob
compon
ligandmembran
interact
may
produc
favor
enthalp
contribut
capabl
compens
entrop
penalti
result
reduc
number
conform
orient
ligand
adopt
within
membran
sargent
et
al
morod
romano
provid
conform
orient
membraneassoci
ligand
favor
receptor
bind
process
less
entropi
requir
word
entrop
advantag
approach
compar
situat
ligand
approach
bind
site
receptor
via
random
walk
solut
castanho
fernand
interest
aspect
divid
bind
process
sever
step
compar
onestep
model
equival
total
free
energi
g
observ
k
lower
energet
requir
individu
step
significantli
increas
overal
reaction
rate
sargent
schwyzer
reason
also
signific
increas
overal
dissoci
rate
impli
ligand
experiment
equilibrium
dissoci
constant
nm
may
dissoci
halfliv
minut
rang
consider
constitut
rational
membran
catalysi
model
schwyzer
sargent
schwyzer
stipul
flexibl
peptid
ligand
bind
membran
first
step
acquir
membraneinduc
conform
peptid
bind
receptor
second
step
fig
accord
view
import
role
attribut
membran
abil
optim
conform
peptid
ligand
enter
fit
bind
site
receptor
greater
eas
membran
catalysi
model
obvious
also
applic
nonpeptid
ligand
irrespect
ligand
applic
receptor
possess
dock
site
requir
depth
lipid
bilay
ligand
acquir
bindingpron
conform
membran
aiello
et
al
castanho
fernand
membran
catalysi
model
support
sever
experiment
observ
exampl
side
chain
deploy
membranebound
state
substanc
p
analogu
found
similar
biolog
activ
chemic
constrain
state
schwyzer
peptid
hormon
glucagon
acth
calcitonin
also
amphiphil
structur
essenti
biolog
activ
kaiser
krzdi
hand
lala
leuenkephalin
may
inact
orient
membran
differ
activ
compound
schwyzer
drug
screen
studi
interact
receptor
ligand
tradit
quantifi
term
affin
yet
increas
awar
vivo
effect
durat
ligand
action
also
dictat
time
period
ligand
resid
receptor
copeland
et
al
tummino
copeland
vauquelin
van
liefd
vivo
resid
halflif
confus
halflif
ligandreceptor
complex
dissoci
inde
halflif
ligandreceptor
complex
measur
condit
new
complex
form
eg
ad
excess
unlabel
ligand
case
radioligand
dissoci
experi
vauquelin
szczuka
instead
vivo
resid
halflif
refer
time
need
halv
receptor
occup
concentr
free
membraneassoci
ligand
less
slowli
declin
via
desorpt
clearanc
degrad
impli
time
complex
still
form
bind
nativ
ligand
molecul
long
still
around
well
rebind
ligand
molecul
previous
dissoci
neighbor
receptor
molecul
vauquelin
szczuka
respect
membran
partit
could
contribut
long
resid
time
number
differ
mechan
equilibrium
point
view
lipophil
molecul
high
membranewat
partit
coeffici
k
p
prefer
resid
lipid
bilay
hydrocarbon
core
without
consid
paramet
accumul
ligand
membran
may
alreadi
increas
vivo
resid
halflif
hyperbol
relationship
free
ligand
concentr
receptor
occup
shown
typic
radioligand
satur
bind
curv
impli
start
alreadi
low
free
ligand
concentr
ie
fig
panel
influenc
initi
receptor
occup
abscissa
percent
total
receptor
concentr
resid
halflif
ordin
free
ligand
halflif
taken
unit
free
ligand
concentr
decreas
exponenti
time
panel
b
high
kp
slow
ligand
desorpt
rate
act
concert
prolong
concentr
membraneassoci
ligand
within
therapeut
window
adapt
herbett
part
receptor
occupi
vivo
resid
halflif
close
halflif
free
ligand
concentr
declin
fig
howev
initi
ligand
concentr
elev
ie
receptor
occupi
vivo
resid
halflif
markedli
exceed
halflif
free
ligand
k
p
refer
ratio
adsorpt
releasedesorpt
rate
ligand
obviou
pharmacokinet
paramet
may
also
affect
ligand
therapeut
action
right
respect
slow
releas
plasma
membran
wide
consid
play
preponder
role
long
durat
action
highli
lipophil
ligand
typic
illustr
hydrophob
adrenerg
receptor
agonist
salmeterol
fig
whose
apt
produc
pseudoirrevers
relax
guinea
pig
trachea
human
bronchi
concentr
johnson
et
al
nial
et
al
link
slow
releas
airway
smooth
muscl
membran
anderson
anderson
et
al
austin
et
al
link
embodi
diffus
microkinet
model
stipul
plasma
membran
act
depotreservoir
ligand
rather
mere
function
inert
substratum
receptor
anderson
coleman
et
al
obvious
slow
desorpt
act
concert
high
k
p
prolong
effect
durat
ligand
fig
propos
case
highli
lipophil
dhp
lacidipin
herbett
lacidipin
higher
k
p
mani
dhp
higher
local
concentr
attain
locat
deeper
lipid
bilay
partit
slower
membran
high
k
p
establish
high
concentr
ligand
within
membran
slow
releas
ensur
concentr
membran
remain
therapeut
threshold
long
period
time
herbett
combin
properti
may
explain
compar
gentl
onset
long
durat
clinic
action
drug
despit
short
plasma
halflif
herbett
howev
membran
partit
could
also
increas
effect
durat
ligand
altern
mechan
intrigu
possibl
ligand
could
undergo
specif
longlast
bind
exosit
membran
auxiliari
site
could
locat
either
receptor
ie
anchor
site
differ
activ
site
suppos
affect
conform
activ
site
via
alloster
mechan
immedi
vicin
membran
exosit
theori
origin
propos
rocha
e
silva
explain
persist
antagonist
activ
histamin
h
receptor
subsequ
adopt
explain
long
durat
action
muscarin
acetylcholin
receptor
agonist
xanomelin
adrenerg
receptor
agonist
salmeterol
fig
johnson
et
al
johnson
coleman
coleman
et
al
christopoulo
et
al
presenc
exosit
impli
dissoci
activ
site
receptor
ligand
free
diffus
away
receptor
constitut
import
differ
microkinet
theori
permit
ligand
freeli
interchang
receptor
activ
site
lipid
bulk
phase
henc
concentr
free
ligand
prone
declin
due
redistribut
degrad
andor
elimin
pathway
concentr
ligand
avail
activ
site
bind
maintain
longer
time
period
case
exosit
bind
green
et
al
major
handicap
exosit
theori
auxiliari
bind
site
hitherto
never
posit
identifi
eg
radioligand
bind
studi
number
experiment
find
even
cast
doubt
valid
theori
bergend
et
al
teschemach
lemoin
et
al
exampl
argu
exosit
salmeterol
display
pharmacolog
specif
high
affin
phenylalkoxyalkyl
side
chain
molecul
side
chain
would
attenu
reassert
behavior
salmeterol
yet
structur
mimet
fail
bergend
et
al
moreov
disagr
exosit
theori
reassert
muscarin
acetylcholin
receptor
agonist
xanomelin
took
place
high
concentr
cell
system
vein
persist
reassert
salmeterolmedi
relax
strip
guinea
pig
trachea
observ
initi
concentr
suffici
elev
bergend
et
al
et
al
provid
support
claim
reassert
agonist
effect
simpli
relat
longlast
associ
plasma
membran
ie
microkinet
theori
term
reassert
hitherto
link
reappear
agonist
effect
yet
term
could
appli
ligand
type
definit
refer
reestablish
receptor
occup
rather
sole
receptor
activ
ligand
washout
aqueou
ligandcontain
solut
temporari
occup
receptor
bind
pocket
competit
ligand
molecul
base
gener
definit
reassert
like
appli
kind
amphiphilichydrophob
ligand
respect
could
well
explain
behavior
aspect
dopamin
receptor
antagonist
h
spiperon
radioligand
bind
studi
intact
recombin
cell
fig
final
retain
dissoci
ligand
compart
small
volum
cell
plasma
membran
could
favor
packeu
et
al
short
intact
cell
preincub
min
c
nm
h
spiperon
specif
ie
butaclamoldisplac
bind
measur
denot
control
bind
coaddit
racloprid
reduc
h
spiperon
bind
control
lane
h
spiperon
raclopridepretr
cell
wash
twice
remov
free
ligand
present
aqueou
solut
final
incub
min
c
buffer
alon
specif
bind
almost
doubl
lane
increas
reflect
genuin
receptor
occup
block
racloprid
concentrationdepend
fashion
lane
lane
potenc
competit
bind
experi
n
panel
b
differ
rate
h
spiperon
dissoci
recombin
cho
cell
membran
prepar
thereof
intact
cell
membran
prepar
thereof
incub
min
c
nm
h
spiperon
h
spiperon
dissoci
c
initi
butaclamol
time
indic
remain
specif
bind
measur
dissoci
experi
also
done
leaki
cell
ie
throughout
presenc
mgml
poreform
agent
filipin
n
propens
rebindreassoci
neighbor
receptor
molecul
compart
could
also
includ
synaps
coomb
goldstein
tortuou
path
blind
pocket
tissu
brain
even
space
cell
monolay
cultur
nicholson
spivak
et
al
radioligand
dissoci
experi
rebind
phenomenon
lead
appar
decreas
radioligand
dissoci
rate
washout
medium
ie
radioligand
rebind
possibl
compar
similar
washout
experi
presenc
unlabel
compet
ligand
high
concentr
ie
radioligand
rebind
effect
prevent
vauquelin
szczuka
base
intact
cell
experi
rebind
recent
shown
extrem
approach
virtual
irrevers
case
lipophil
type
dopamin
receptor
antagonist
spiperon
packeu
et
al
cb
type
cannabinoid
receptor
invers
agonist
taranab
szczuka
et
al
experi
compat
abil
cell
membran
confin
exacerb
rebind
phenomena
lipophil
drug
suggest
recent
simul
studi
szczuka
et
al
rebind
could
explain
longlast
effect
salmeterol
pertin
exosit
model
line
rebind
could
also
explain
need
simultan
presenc
receptor
lipid
environ
washresist
xanomelin
bind
take
place
et
al
final
tortuos
extracellular
space
tissu
could
alreadi
limit
diffus
molecul
gener
repeat
partit
cell
membran
like
exacerb
process
case
hydrophob
ligand
lovich
et
al
nicholson
retain
hydrophob
ligand
target
tissu
repeat
partit
could
greatli
contribut
oftenobserv
longlast
effect
molecul
vivo
well
vitro
experi
intact
tissu
socal
nonspecif
partit
amphiphilichydrophob
ligand
plasma
membran
may
exert
control
receptor
bind
characterist
mani
way
alter
time
need
reach
receptor
molecul
conform
receptordomain
toward
final
approach
take
place
effect
along
accumul
ligand
small
volum
around
receptor
may
affect
associ
rate
affin
well
vivo
resid
time
receptor
howev
gener
rule
hard
formul
membran
partit
alway
exert
posit
influenc
ligand
receptor
bind
characterist
novel
membraneconnect
concept
includ
exosit
bind
ligand
transloc
receptor
transmembran
domain
advanc
well
lack
tangibl
proof
physic
realiti
concept
like
remain
matter
debat
time
come
addit
new
question
recent
emerg
antagonist
display
distinct
receptorbind
kinet
intact
cell
system
compar
leaki
cell
membran
prepar
thereof
hara
et
al
fieren
et
al
smith
et
al
addit
exampl
thereof
shown
fig
research
area
hydrophobicamphiphil
ligandreceptor
interact
gener
highli
desir
especi
increas
awar
receptorbind
kinet
may
influenc
vivo
effect
durat
ligand
action
accordingli
kinet
issu
also
address
screen
studi
